Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Translational Research|January 17, 2022
miR-125a-5p-targeted regulation of TRA2β expression inhibits proliferation and metastasis of hepatocellular carcinoma cellsJunde Zhou, Linna Wang, Yunfu Cui, et al.
BMJ Open|April 30, 2025
Tremelimumab plus durvalumab versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: a cost-effectiveness analysis from the US payer perspectiveShuqiao Cheng, Bin Li, Lanhua Tang, et al.
BMC Medicine|February 22, 2023
Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation studyYiwen Long, Lanhua Tang, Yangying Zhou, et al.
International Journal of General Medicine|February 4, 2022
Construction of Molecular Subtypes and Related Prognostic and Immune Response Models Based on M2 Macrophages in GlioblastomaKai Xiao, Shushan Zhao, Jian Yuan, et al.
The Journal of International Medical Research|June 14, 2017
Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis: PDGF-BB mediated by estradiol in womenLanhua Tang, Zhuying Xia, Zhongwei Luo, et al.
Oncotarget|August 18, 2016
Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studiesLanhua Tang, Huabin Hu, Huai Liu, et al.
Virology Journal|September 7, 2010
Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic reviewShushan Zhao, Lanhua Tang, Xuegong Fan, et al.
Molecular Biology Reports|January 29, 2014
The association of rs1149048 polymorphism in matrilin-1(MATN1) gene with adolescent idiopathic scoliosis susceptibility: a meta-analysisHongqi Zhang, Shushan Zhao, Zijin Zhao, et al.
The Journal of International Medical Research|September 15, 2021
Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer riskShushan Zhao, Ping Liu, Zhe Ruan, et al.
Annals of Translational Medicine|November 4, 2021
Atezolizumab compared to chemotherapy for first-line treatment in non-small cell lung cancer with high PD-L1 expression: a cost-effectiveness analysis from US and Chinese perspectivesShuqiao Cheng, Rui Pei, Jianhuang Li, et al.
Pageof 3